SEARCH

SEARCH BY CITATION

References

  • Albina, J. E., Reichner, J. S. (1998) Role of nitric oxide in mediation of macrophage cytotoxicity and apoptosis. Cancer Metastasis Rev. 17: 3953.
  • Andrew, P. J., Harant, H., Lindley, I. J. (1995) Nitric oxide regulates IL-8 expression in melanoma cells at the transcriptional level. Biochem. Biophys. Res. Commun. 214: 949956.
  • Azizzadeh, B., Yip, H. T., Blackwell, K. E., Horvath, S., Calcaterra, T. C., Buga, G. M., Ignarro, L. J., Wang, M. B. (2001) Nitric oxide improves cisplatin cytotoxicity in head and neck squamous cell carcinoma. Laryngoscope 111: 18961900.
  • Babal, P., Pechanova, O., Bernatova, I., Stvrtina, S. (1997) Chronic inhibition of NO synthesis produces myocardial fibrosis and arterialmedia hyperplasia. Histol. Histopathol. 12: 623629.
  • Bal-Price, A., Brown, G. C. (2000) Nitric-oxide-induced necrosis and apoptosis in PC12 cells mediated by mitochondria. J. Neurochem. 75: 14551464.
  • Brennan, P. A. (2000) The actions and interactions of nitric oxide in solid tumours. Eur. J. Surg. Oncol. 26: 434437.
  • Bulut, A. S., Erden, E., Sak, S. D., Doruk, H., Kursun, N., Dincol, D. (2005) Significance of inducible nitric oxide synthase expression in benign and malignant breast epithelium: an immunohistochemical study of 151 cases. Virchows Arch. 447: 2430.
  • Chao, J. I., Kuo, P. C., Hsu, T. S. (2004) Down-regulation of survivin in nitric oxide-induced cell growth inhibition and apoptosis of the human lung carcinoma cells. J. Biol. Chem. 279: 2026720276.
  • Charalambous, C., Pen, L. B., Su, Y. S., Milan, J., Chen, T. C., Hofman, F. M. (2005) Interleukin-8 differentially regulates migration of tumor-associated and normal human brain endothelial cells. Cancer Res. 65: 1034710354.
  • Chen, H. H., Su, W. C., Chou, C. Y., Guo, H. R., Ho, S. Y., Que, J., Lee, W. Y. (2005) Increased expression of nitric oxide synthase and cyclooxygenase-2 is associated with poor survival in cervical cancer treated with radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 63: 10931100.
  • Chin, K., Kurashima, Y., Ogura, T., Tajiri, H., Yoshida, S., Esumi, H. (1997) Induction of vascular endothelial growth factor by nitric oxide in human glioblastoma and hepatocellular carcinoma cells. Oncogene 15: 437442.
  • Chinje, E. C., Stratford, I. J. (1997) Role of nitric oxide in growth of solid tumours: a balancing act. Essays Biochem. 32: 6172.
  • Chung, P., Cook, T., Liu, K., Vodovotz, Y., Zamora, R., Finkelstein, S., Billiar, T., Blumberg, D. (2003) Overexpression of the human inducible nitric oxide synthase gene enhances radiation-induced apoptosis in colorectal cancer cells via a caspase-dependent mechanism. Nitric Oxide 8: 119126.
  • Cook, T., Wang, Z., Alber, S., Liu, K., Watkins, S. C., Vodovotz, Y., Billiar, T. R., Blumberg, D. (2004) Nitric oxide and ionizing radiation synergistically promote apoptosis and growth inhibition of cancer by activating p53. Cancer Res. 64: 80158021.
  • Dedon, P. C., Tannenbaum, S. R. (2004) Reactive nitrogen species in the chemical biology of inflammation. Arc h. Biochem. Biophys. 423: 1222.
  • De Santo, C., Serafini, P., Marigo, I., Dolcetti, L., Bolla, M., del Soldato, P., Melani, C., Guiducci, C., Colombo, M. P., Iezzi, M., Musiani, P., Zanovello, P., Bronte, V. (2005) Nitroaspirin corrects immune dysfunction in tumor-bearing hosts and promotes tumor eradication by cancer vaccination. Proc. Natl. Acad. Sci. USA 102: 41854190.
  • De Wilt, J. H., Manusama, E. R., Van Etten, B., Van Tiel, S. T., Jorna, A. S., Seynhaeve, A. L., ten Hagen, T. L., Eggermont, A. M. (2000) Nitric oxide synthase inhibition results in synergistic anti-tumour activity with melphalan and tumour necrosis factor alpha-based isolated limb perfusions. Br. J. Cancer 83: 11761182.
  • Dewey, D. L. (1960) Effect of oxygen and nitric oxide on the radio-sensitivity of human cells in tissue culture. Nature 186: 780782.
  • Duenas-Gonzalez, A., Isales, C. M., del Abad-Hernandez, Mar M., Gonzalez-Sarmiento, R., Sangueza, O., Rodriguez-Commes, J. (1997) Expression of inducible nitric oxide synthase in breast cancer correlates with metastatic disease. Mod. Pathol. 10: 645649.
  • Ekmekcioglu, S., Tang, C. H., Grimm, E. A. (2005) NO news is not necessarily good news in cancer. Curr. Cancer Drug Targets 5: 103115.
  • Evig, C. B., Kelley, E. E., Weydert, C. J., Chu, Y., Buettner, G. R., Burns, C. P. (2004) Endogenous production and exogenous exposure to nitric oxide augment doxorubicin cytotoxicity for breast cancer cells but not cardiac myoblasts. Nitric Oxide 10: 119129.
  • Fabbri, F., Brigliadori, G., Ulivi, P., Tesei, A., Vannini, I., Rosetti, M., Bravaccini, S., Amadori, D., Bolla, M., Zoli, W. (2005) Pro-apoptotic effect of a nitric oxide-donating NSAID, NCX 4040, on bladder carcinoma cells. Apoptosis 10: 10951103.
  • Folkes, L. K., Wardman, P. (2004) Kinetics of the reaction between nitric oxide and glutathione: implications for thiol depletion in cells. Free Radic. Biol. Med. 37: 549556.
  • Folkman, J. (1990) What is the evidence that tumors are angiogenesis dependent J. Natl. Cancer Inst. 82: 46.
  • Ford, E., Hughes, M. N., Wardman, P. (2002) Kinetics of the reactions of nitrogen dioxide with glutathione, cysteine, and uric acid at physiological pH. Free Radic. Biol. Med. 32: 13141323.
  • Franchi, A., Santucci, M., Masini, E., Sardi, I., Paglierani, M., Gallo, O. (2002) Expression of matrix metalloproteinase 1, matrix metalloproteinase 2, and matrix metalloproteinase 9 in carcinoma of the head and neck. Cancer 95: 19021910.
  • Franchi, A., Massi, D., Santucci, M., Masini, E., Degl'innocenti, D. R., Magnelli, L., Fanti, E., Naldini, A., Ardinghi, C., Carraro, F., Gallo, O. (2005) Inducible nitric oxide synthase activity correlates with lymphangiogenesis and vascular endothelial growth factor-C expression in head and neck squamous cell carcinoma. J. Pathol. 208: 439445.
  • Frank, S., Stallmeyer, B., Kampfer, H., Kolb, N., Pfeilschifter, J. (1999a) Nitric oxide triggers enhanced induction of vascular endothelial growth factor expression in cultured keratinocytes (HaCaT) and during cutaneous wound repair. FASEB J. 113: 20022014.
  • Frank, S., Stallmeyer, B., Kampfer, H., Schaffner, C., Pfeilschifter, J. (1999b) Differential regulation of vascular endothelial growth factor and its receptor fms-like-tyrosine kinase is mediated by nitric oxide in rat renal mesangial cells. Biochem. J. 338: 367374.
  • Fukumura, D., Yuan, F., Endo, M., Jain, R. K. (1997) Role of nitric oxide in tumor microcirculation. Blood flow, vascular permeability, and leukocyte-endothelial interactions. Am. J. Pathol. 150: 713725.
  • Gansauge, S., Nussler, A. K., Beger, H. G., Gansauge, F. (1998) Nitric oxide-induced apoptosis in human pancreatic carcinoma cell lines is associated with a G1-arrest and an increase of the cyclin-dependent kinase inhibitor p21WAF1/CIP1. Cell Growth Differ. 9: 611617.
  • Gao, J., Liu, X., Rigas, B. (2005) Nitric oxide-donating aspirin induces apoptosis in human colon cancer cells through induction of oxidative stress. Proc. Natl. Acad. Sci. USA 102: 1720717212.
  • Gatti, G., Simsek, S., Zurrida, S., Kurne, A., Giannetti, I., Demirer, S., Smeets, A., Caldarella, P., Vento, A. R., Giraldo, A., Luini, A. (2004) Possible role of nitric oxide in the biology of breast carcinoma: review of the available literature. Breast 13: 16.
  • Gray, L. H., Conger, A. D., Ebert, M., Hornsey, S., Scott, O. C. (1953) The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy. Br. J. Radiol. 26: 638648.
  • Gray, L. H., Green, F. O., Hawes, C. A. (1958) Effect of nitric oxide on the radiosensitivity of tumour cells. Nature 182: 952953.
  • Graziewicz, M., Wink, D. A., Laval, F. (1996) Nitric oxide inhibits DNA ligase activity. Potential mechanisms for NO mediated DNA damage. Carcinogenesis 17: 25012505.
  • Griffin, R. J., Makepeace, C. M., Hur, W. J., Song, C. W. (1996) Radiosensitization of hypoxic tumor cells in vitro by nitric oxide. Int. J. Radiat. Oncol. Biol. Phys. 36: 377383.
  • Guo, J.-P., Panday, M. M., Consigny, P. M., Lefer, A. M. (1995) Mechanisms of vascular preservation by a novel NO donor following carotid artery intimal injury. Am. J. Physiol. 269: H1122H1131.
  • Gursoy-Ozdemir, Y., Bolay, H., Saribas, O., Dalkara, T. (2000) Role of endothelial nitric oxide generation and peroxynitrite formation in reperfusion injury after focal cerebral ischemia. Stroke 31: 19741980.
  • Halliwell, B., Zhao, K., Whiteman, M. (1999) Nitric oxide and peroxynitrite. The ugly, the uglier and the not so good: a personal view of recent controversies. Free Radic. Res. 31: 651669.
  • Hara, A., Okayasu, I. (2004) Cyclooxygenase-2 and inducible nitric oxide synthase expression in human astrocytic gliomas: correlation with angiogenesis and prognostic significance. Acta Neuropathol (Berl) 108: 4348.
  • Harada, K., Supriatno, Kawaguchi, S., Tomitaro, O., Yoshida, H., Sato, M. (2004) Overexpression of iNOS gene suppresses the tumorigenicity and metastasis of oral cancer cells. In Vivo 18: 449455.
  • Harmey, J. H., Bucana, C. D., Lu, W., Byrne, A. M., McDonnell, S., Lynch, C., Bouchier-Hayes, D., Dong, Z. (2002) Lipopolysaccharide-induced metastatic growth is associated with increased angiogenesis, vascular permeability and tumor cell invasion. Int. J. Cancer 101: 415422.
  • Harris, A. L. (2002) Hypoxia — a key regulatory factor in tumour growth. Nat. Rev. Cancer 2: 3847.
  • Hegardt, P., Widegren, B., Li, L., Sjogren, B., Kjellman, C., Sur, I., Sjogren, H. O. (2001) Nitric oxide synthase inhibitor and IL-18 enhance the anti-tumor immune response of rats carrying an intrahepatic colon carcinoma. Cancer Immunol. Immunother. 50: 491501.
  • Hellmuth, M., Paulukat, J., Ninic, R., Pfeilschifter, J., Muhl, H. (2004) Nitric oxide differentially regulates pro- and anti-angiogenic markers in DLD-1 colon carcinoma cells. FEBS Lett. 563: 98102.
  • Hino, M., Kohchi, C., Nishizawa, T., Yoshida, A., Nakata, K., Inagawa, H., Hori, H., Makino, K., Terada, H., Soma, G. (2005) Innate-immune therapy for lung carcinoma based on tissue-macrophage activation with lipopolysaccharide. Anticancer Res. 25: 37473754.
  • Howard-Flanders, P. (1957) Effect of nitric oxide on the radiosensitivity of bacteria. Nature 180: 11911192.
  • Hu, D. E., Dyke, S. O., Moore, A. M., Thomsen, L. L., Brindle, K. M. (2004) Tumor cell-derived nitric oxide is involved in the immune-rejection of an immunogenic murine lymphoma. Cancer Res. 64: 152161.
  • Huguenin, S., Vacherot, F., Kheuang, L., Fleury-Feith, J., Jaurand, M. C., Bolla, M., Riffaud, J. P., Chopin, D. K. (2004) Antiproliferative effect of nitrosulindac (NCX 1102), a new nitric oxide-donating non-steroidal anti-inflammatory drug, on human bladder carcinoma cell lines. Mol. Cancer Ther. 3: 291298.
  • Huguenin, S., Vacherot, F., Fleury-Feith, J., Riffaud, J. P., Chopin, D. K., Bolla, M., Jaurand, M. C. (2005) Evaluation of the antitumoral potential of different nitric oxide-donating non-steroidal anti-inflammatory drugs (NO-NSAIDs) on human urological tumor cell lines. Cancer Lett. 218: 163170.
  • Hussain, S. P., Trivers, G. E., Hofseth, L. J., He, P., Shaikh, I., Mechanic, L. E., Doja, S., Jiang, W., Subleski, J., Shorts, L., Haines, D., Laubach, V. E., Wiltrout, R. H., Djurickovic, D., Harris, C. C. (2004) Nitric oxide, a mediator of inflammation, suppresses tumorigenesis. Cancer Res. 64: 68496853.
  • Isenberg, J. S., Ridnour, L. A., Perruccio, E. M., Espey, M. G., Wink, D. A., Roberts, D. D. (2005) Thrombospondin-1 inhibits endothelial cell responses to nitric oxide in a cGMP dependent manner. Proc. Natl. Acad. Sci. USA 102: 1314113146.
  • Ishii, Y., Ogura, T., Tatemichi, M., Fujisawa, H., Otsuka, F., Esumi, H. (2003) Induction of matrix metalloproteinase gene transcription by nitric oxide and mechanisms of MMP-1 gene induction in human melanoma cell lines. Int. J. Cancer 103: 161168.
  • Jadeski, L. C., Lala, P. K. (1999) Nitric oxide synthase inhibition by N(G)-nitro-L-arginine methyl ester inhibits tumor-induced angiogenesis in mammary tumors. Am. J. Pathol. 155: 13811390.
  • Jadeski, L. C., Hum, K. O., Chakraborty, C., Lala, P K. (2000) Nitric oxide promotes murine mammary tumour growth and metastasis by stimulating tumour cell migration, invasiveness and angiogenesis. Int. J. Cancer 86: 3039.
  • Jadeski, L. C., Chakraborty, C., Lala, P. K. (2003) Nitric oxidemediated promotion of mammary tumour cell migration requires sequential activation of nitric oxide synthase, guanylate cyclase and mitogen-activated protein kinase. Int. J. Cancer 106: 496504.
  • Janssens, M. Y., Van den Berge, D. L., Verovski, V. N., Monsaert, C., Storme, G. A. (1998) Activation of inducible nitric oxide synthase results in nitric oxide-mediated radiosensitization of hypoxic EMT-6 tumor cells. Cancer Res. 58: 56465648.
  • Janssens, M. Y., Verovski, V. N., Van den Berge, D. L., Monsaert, C., Storme, G. A. (1999) Radiosensitization of hypoxic tumour cells by S-nitroso-N-acetylpenicillamine implicates a bioreductive mechanism of nitric oxide generation. Br. J. Cancer 79: 10851089.
  • Jia, L., Schweizer, J., Wang, Y., Cerna, C., Wong, H., Revilla, M. (2003) Effect of nitric oxide on cytotoxicity of Taxol: enhanced Taxol transcellular permeability. Biochem. Pharmacol. 66: 21932199.
  • Jones, M. K., Tsugawa, K., Tarnawski, A. S., Baatar, D. (2004) Dual actions of nitric oxide on angiogenesis: possible roles of PKC, ERK, and AP-1. Biochem. Biophys. Res. Commun. 318: 520528.
  • Jordan, B. F., Misson, P., Demeure, R., Baudelet, C., Beghein, N., Gallez, B. (2000) Changes in tumor oxygenation/perfusion induced by the NO donor, isosorbidedinitrate, in comparison with carbogen: monitoring by EPR and MRI. Int. J. Radiat. Oncol. Biol. Phys. 48: 565570.
  • Jourd'heuil, D., Jourd'heuil, F. L., Kutchukian, P. S., Musah, R. A., Wink, D. A., Grisham, M. B. (2001) Reaction of superoxide and nitric oxide with peroxynitrite. Implications for peroxynitritemediated oxidation reactions in vivo. J. Biol. Chem. 276: 2879928805.
  • Juang, S. H., Xie, K., Xu, L., Wang, Y., Yoneda, J., Fidler, I. J. (1997) Use of retroviral vectors encoding murine inducible nitric oxide synthase gene to suppress tumorigenicity and cancer metastasis of murine melanoma. Cancer Biother. Radiopharm. 12: 167175.
  • Juang, S. H., Xie, K., Xu, L., Shi, Q., Wang, Y., Yoneda, J., Fidler, I. J. (1998) Suppression of tumorigenicity and metastasis of human renal carcinoma cells by infection with retroviral vectors harboring the murine inducible nitric oxide synthase gene. Hum. Gene Ther. 9: 845854.
  • Jurasz, P., Sawicki, G., Duszyk, M., Sawicka, J., Miranda, C., Mayers, I., Radomski, M. W. (2001) Matrix metalloproteinase 2 in tumor cell-induced platelet aggregation: regulation by nitric oxide. Cancer Res. 61: 376382.
  • Kanagy, N. L. (1997) Increased vascular responsiveness to alpha 2-adrenergic stimulation during NOS inhibition-induced hypertension. Am. J. Physiol. 273: H2756H2764.
  • Kashfi, K., Rigas, B. (2005) Molecular targets of nitric-oxide-donating aspirin in cancer. Biochem. Soc. Trans. 33: 701704.
  • Kashiwagi, S., Izumi, Y., Gohongi, T., Demou, Z. N., Xu, L., Huang, P. L., Buerk, D. G., Munn, L. L., Jain, R. K., Fukumura, D. (2005) NO mediates mural cell recruitment and vessel morphogenesis in murine melanomas and tissue-engineered blood vessels. J. Clin. Invest. 115: 18161827.
  • Kasper, H. U., Wolf, H., Drebber, U., Wolf, H. K., Kern, M. A. (2004) Expression of inducible nitric oxide synthase and cyclooxygenase-2 in pancreatic adenocarcinoma: correlation with microvessel density. World J. Gastroenterol. 10: 19181922.
  • Kennovin, G. D., Hirst, D. G., Stratford, M. R. L., Flitney, F. W. (1994) Inducible nitric oxide synthase is expressed in tumour-associated vasculature: inhibition retards tumour growth. In: Moncada, S., Feelisch, M., Busse, R., Higgs, E. A. (eds) The Biology of nitric oxide. Portland Press, London, pp 259263.
  • Konovalova, N. P., Goncharova, S. A., Volkova, L. M., Rajewskaya, T. A., Eremenko, L. T., Korolev, A. M. (2003) Nitric oxide donor increases the efficiency of cytostatic therapy and retards the development of drug resistance. Nitric Oxide 8: 5964.
  • Korbelik, M., Parkins, C. S., Shibuya, H., Cecic, I., Stratford, M. R., Chaplin, D. J. (2000) Nitric oxide production by tumour tissue: impact on the response to photodynamic therapy. Br. J. Cancer 82: 18351843.
  • Kroncke, K. D. (2001) Cysteine-Zn2+ complexes: unique molecular switches for inducible nitric oxide synthase-derived NO. FASEB J. 15: 25032507.
  • Kroncke, K. D., Klotz, L. O., Suschek, C. V., Sies, H. (2002) Comparing nitrosative versus oxidative stress toward zinc finger-dependent transcription. Unique role for NO. J. Biol. Chem. 277: 1329413301.
  • Kuroki, M. (2004) Gene therapy in cancer via use of a retrovector having a tumor specificity and expressing inducible nitric oxide synthase. Methods Mol. Biol. 279: 201211.
  • Kuroki, M., Arakawa, F., Khare, P. D., Kuroki, M., Liao, S., Matsumoto, H., Abe, H., Imakiire, T. (2000) Specific targeting strategies of cancer gene therapy using a single-chain variable fragment (scFv) with a high affinity for CEA. Anticancer Res. 20: 40674071.
  • Kwak, J. Y., Han, M. K., Choi, K. S., Park, I. H., Park, S. Y., Sohn, M. H., Kim, U. H., McGregor, J. R., Samlowski, W. E., Yim, C. Y. (2000) Cytokines secreted by lymphokine-activated killer cells induce endogenous nitric oxide synthesis and apoptosis in DLD-1 colon cancer cells. Cell Immunol. 203: 8494.
  • Lala, P. K., Chakraborty, C. (2001) Role of nitric oxide in carcinogenesis and tumour progression. Lancet Oncol. 2: 149156.
  • Laskin, J. D., Heck, D. E., Gardner, C. R., Laskin, D. L. (2001) Prooxidant and antioxidant functions of nitric oxide in liver toxicity. Antioxid. Redox Signal. 3: 261271.
  • Lau, Y.-T., Ma, W.-C. (1996) Nitric oxide inhibits migration of cultured endothelial cells. Biochem. Biophys. Res. Commun. 221: 670674.
  • Laval, F., Wink D. A. (1997) Inhibition by nitric oxide of the repair protein O6-methylguanin-DNA-methyltransferase. Carcinogenesis 15: 443447.
  • Le, X., Wei, D., Huang, S., Lancaster, J. R., Xie, K. (2005) Nitric oxide synthase II suppresses the growth and metastasis of human cancer regardless of its up-regulation of protumor factors. Proc Natl Acad Sci USA 102: 87588763.
  • Lechner, M., Lirk, P., Rieder, J. (2005) Inducible nitric oxide synthase (iNOS) in tumor biology: the two sides of the same coin. Semin. Cancer Biol. 15: 277289.
  • Leiro, J., Iglesias, R., Parama, A., Sanmartin, M. L., Ubeira, F. M. (2001) Respiratory burst responses of rat macrophages to micro-sporidian spores. Exp. Parasitol. 98: 19.
  • Li, H., Hu, J., Xin, W., Zhao, B. (2000) Production and interaction of oxygen and nitric oxide free radicals in PMA stimulated macrophages during the respiratory burst. Redox Rep. 5: 353358.
  • Li, W., Xu, R. J., Jiang, L. H., Shi, J., Long, X., Fan, B. (2005) Expression of cyclooxygenase-2 and inducible nitric oxide synthase correlates with tumor angiogenesis in endometrial carcinoma. Med. Oncol. 22: 6370.
  • Liu, J., Li, C., Qu, W., Leslie, E., Bonifant, C. L., Buzard, G. S., Saavedra, J. E., Keefer, L. K., Waalkes, M. P. (2004) Nitric oxide prodrugs and metallochemotherapeutics: JS-K and CB-3-100 enhance arsenic and cisplatin cytolethality by increasing cellular accumulation. Mol. Cancer Ther. 3: 709714.
  • Loibl, S., Buck, A., Strank, C., Von Minckwitz, G., Roller, M., Sinn, H. P., Schini-Kerth, V., Solbach, C., Strebhardt, K., Kaufmann, M. (2005) The role of early expression of inducible nitric oxide synthase in human breast cancer. Eur. J. Cancer 41: 265271.
  • Marrogi, A. J., Travis, W. D., Welsh, J. A., Khan, M. A., Rahim, H., Tazelaar, H., Pairolero, P., Trastek, V., Jett, J., Caporaso, N. E., Liotta, L. A., Harris, C. C. (2000) Nitric oxide synthase, cyclooxygenase 2, and vascular endothelial growth factor in the angiogenesis of non-small cell lung carcinoma. Clin. Cancer Res. 6: 47391744.
  • Matsumoto, H., Hayashi, S., Hatashita, M., Ohnishi, K., Shioura, H., Ohtsubo, T., Kitai, R., Ohnishi, T., Kano, E. (2001) Induction of radioresistance by a nitric oxide-mediated bystander effect. Radiat. Res. 155: 387396.
  • Matsunaga, T., Weihrauch, D. W., Moniz, M. C., Tessmer, J., Warltier, D. C., Chilian, W. M. (2002) Angiostatin inhibits coronary angiogenesis during impaired production of nitric oxide. Circulation 105: 21852191.
  • Meyer, R. E., Shan, S., DeAngelo, J., Dodge, R. K., Bonaventura, J., Ong, E. T., Dewhirst, M. W. (1995) Nitric oxide synthase inhibition irreversibly decreases perfusion in the R3230Ac rat mammary adenocarcinoma. Br. J. Cancer 71: 11691174.
  • Mitchell, J. B., Wink, D. A., DeGraff, W., Gamson, J., Keefer, L. K., Krishna, M. C. (1993) Hypoxic mammalian cell radiosensitization by nitric oxide. Cancer Res. 53: 58455848.
  • Mitchell, J. B., Cook, J. A., Krishna, M. C., DeGraff, W., Gamson, J., Fisher, J., Christodoulou, D., Wink, D. A. (1996) Radiation sensitisation by nitric oxide releasing agents. Br. J. Cancer 27(Suppl.): S181184.
  • Mitchell, J. B., DeGraff, W., Kimi, S., Cook, J. A., Gamson, J., Christodoulou, D., Feelisch, M., Wink, D. A. (1998) Redox generation of nitric oxide to radiosensitize hypoxic cells. Int. J. Radiat. Oncol. Biol. Phys. 42: 795798.
  • Moncada, S. (1999) Nitric oxide: discovery and impact on clinical medicine. J. R. Soc. Med. 92: 164169.
  • Moncada, S., Higgs, E. A. (1991) Endogenous nitric oxide: physiology, pathology and clinical relevance. Eur. J. Clin. Invest. 21: 361374.
  • Mortensen, K., Skouv, J., Hougaard, D. M., Larsson, L. I. (1999) Endogenous endothelial cell nitric-oxide synthase modulates apoptosis in cultured breast cancer cells and is transcriptionally regulated by p53. J. Biol. Chem. 274: 3767937684.
  • Murohara, T., Asahara, T., Silver, M., Bauters, C., Masuda, H., Kalka, C., Kearney, M., Chen, D., Symes, J. F., Fishman, M. C., Huang, P. L., Isner, J. M. (1998) Nitric oxide synthase modulates angiogenesis in response to tissue ischemia. J. Clin. Invest. 101: 25672578.
  • Nabah, Y. N., Mateo, T., Cerda-Nicolas, M., Alvarez, A., Martinez, M., Issekutz, A. C., Sanz, M. J. (2005) L-NAME induces direct arteriolar leukocyte adhesion, which is mainly mediated by angiotensin-II. Microcirculation 12: 443453.
  • Orucevic, A., Lala, P. K. (1996) Effects of N(G)-Nitro-L-arginine methyl ester, an inhibitor of nitric oxide synthesis, on IL-2-induced LAK cell generation in vivo and in vitro in healthy and tumor-bearing mice. Cell Immunol. 169: 125132.
  • Oshima, T., Imada, T., Nagashima, Y., Cho, H., Shiozawa, M., Rino, Y., Takanashi, Y. (2001) Role of nitric oxide in human gastric cancer cells treated with 5 fluorouracil. Oncol. Rep. 8: 847849.
  • Osorio, J. C., Recchia, F. A. (2000) The role of nitric oxide in metabolism regulation: from basic sciences to the clinical setting. Intensive Care Med. 26: 13951398.
  • Palmer, R. M., Ferrige, A. G., Moncada, S. (1987) Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327: 524526.
  • Pan, J. W., Zhan, R. Y., Tong, Y., Zhou, Y. Q., Zhang, M. (2005) Expression of endothelial nitric oxide synthase and vascular endothelial growth factor in association with neovascularization in human primary astrocytoma. J. Zhejiang Univ. Sci. B. 6: 693698.
  • Pechanova, O., Bernatova, I., Babal, P., Martinez, M. C., Kysela, S., Stvrtina, S., Andriantsitohaina, R. (2004) Red wine polyphenols prevent cardiovascular alterations in L-NAME-induced hypertension. J. Hypertens. 22: 15511559.
  • Pervin, S., Singh, R., Gau, C. L., Edamatsu, H., Tamanoi, F., Chaudhuri, G. (2001) Potentiation of nitric oxide-induced apoptosis of MDA-MB-468 cells by farnesyltransferase inhibitor: implications in breast cancer. Cancer Res. 61: 47014706.
  • Phillips, P. G., Birnby, L. M. (2004) Nitric oxide modulates caveo-lin-1 and matrix metalloproteinase-9 expression and distribution at the endothelial cell/tumor cell interface. Am. J. Physiol. Lung Cell. Mol. Physiol. 286: L1055L1065.
  • Pipili-Synetos, E., Sakkoula, E., Haralabopoulos, G., Andriopoulou, P., Peristeris, P., Maragoudakis, M. E. (1994) Evidence that nitric oxide is an endogenous antiangiogenic mediator. Br. J. Pharmacol. 111: 894902.
  • Powell, J. A., Mohamed, S. N., Kerr, J. S., Mousa, S. A. (2000) Antiangiogenesis efficacy of nitric oxide donors. J. Cell Biochem. 80: 104114.
  • Puhakka, A., Kinnula, V., Napankangas, U., Saily, M., Koistinen, P., Paakko, P., Soini, Y. (2003) High expression of nitric oxide synthases is a favorable prognostic sign in non-small cell lung carcinoma. APMIS 111: 11371146.
  • Raspollini, M. R., Amunni, G., Villanucci, A., Boddi, V., Baroni, G., Taddei, A., Taddei, G. L. (2004) Expression of inducible nitric oxide synthase and cyclooxygenase-2 in ovarian cancer: correlation with clinical outcome. Gynecol. Oncol. 92: 806812.
  • RayChaudhury, A., Frischer, H., Malik, A. B. (1996) Inhibition of endothelial cell proliferation and bFGF-induced phenotypic modulation by nitric oxide. J. Cell Biochem. 63: 125134.
  • Ridnour, L. A., Isenberg, J. S., Espey, M. G., Thomas, D. D., Roberts, D. D., Wink, D. A. (2005) Nitric oxide regulates angiogenesis through a functional switch involving thrombospondin-1. Proc. Natl. Acad. Sci. USA 102: 1314713152.
  • Royle, J. S., Ross, J. A., Ansell, I., Bollina, P., Tulloch, D. N., Habib, F.K. (2004) Nitric oxide donating nonsteroidal anti-inflammatory drugs induce apoptosis in human prostate cancer cell systems and human prostatic stroma via caspase-3. J. Urol. 172: 338344.
  • Rubio, L., Vera-Sempere, F. J., Lopez-Guerrero, J. A., Padilla, J., Moreno-Baylach, M. J. (2005) A risk model for non-small cell lung cancer using clinicopathological variables, angiogenesis and oncoprotein expression. Anticancer Res. 25: 497504.
  • Schimmel, M., Bauer, G. (2001) Selective apoptosis induction in transformed fibroblasts by B cell lines: involvement of reactive oxygen and nitrogen species. Int. J. Oncol. 19: 299304.
  • Shao, C., Stewart, V., Folkard, M., Michael, B. D., Prise, K. M. (2003) Nitric oxide-mediated signaling in the bystander response of individually targeted glioma cells. Cancer Res 63: 84378442.
  • Shizukuda, Y., Tang, S., Yokota, R., Ware, J. A. (1999) Vascular endothelial growth factor-induced endothelial cell migration and proliferation depend on a nitric oxide-mediated decrease in protein kinaseCdelta activity. Circ. Res. 85: 247256.
  • Sidorkina, O., Espey, M. G., Miranda, K. M., Wink, D. A., Laval, J. (2003) Inhibition of poly(ADP-RIBOSE) polymerase (PARP) by nitric oxide and reactive nitrogen oxide species. Free Radic. Biol. Med. 35: 14311438.
  • Sokolov, M. V., Smilenov, L. B., Hall, E. J., Panyutin, I. G., Bonner, W. M., Sedelnikova, O. A. (2005) Ionizing radiation induces DNA double-strand breaks in bystander primary human fibroblasts. Oncogene 24: 72577265.
  • Soler, M. N., Bobe, P., Benihoud, K., Lemaire, G., Roos, B. A., Lausson, S. (2000) Gene therapy of rat medullary thyroid cancer by naked nitric oxide synthase II DNA injection. J. Gene Med. 2: 344352.
  • Somers, M. J., Harrison, D. G. (1999) Reactive oxygen species and the control of vasomotor tone. Curr. Hypertens. Rep. 1: 102108.
  • Son, K. K., Hall, K. J. (2000) Nitric oxide-mediated tumor cell killing of cisplatin-based interferon-gamma gene therapy in murine ovarian carcinoma. Cancer Gene Ther. 7: 13241328.
  • Sonveaux, P., Brouet, A., Havaux, X., Gregoire, V., Dessy, C., Balligand, J. L., Feron, O. (2003) Irradiation-induced angiogenesis through the up-regulation of the nitric oxide pathway: implications for tumor radiotherapy. Cancer Res. 63: 10121019.
  • Srivastava, R. C., Farookh, A., Ahmad, N., Misra, M., Hasan, S. K., Husain, M. M. (1996) Evidence for the involvement of nitric oxide in cisplatin-induced toxicity in rats. Biometals 9: 139142.
  • Swaroop, G. R., Malcolm, G. P., Kelly, P. A., Ritchie, I., Whittle, I. R. (1998) Effects of nitric oxide modulation on tumour blood flow and microvascular permeability in C6 glioma. Neuroreport 9: 25772581.
  • Szabo, C., Ohshima, H. (1997) DNA damage induced by peroxynitrite: subsequent biological effects. Nitric Oxide 1: 373385.
  • Thomsen, L. L., Scott, J. M., Topley, P., Knowles, R. G., Keerie, A. J., Frend, A. J. (1997) Selective inhibition of inducible nitric oxide synthase inhibits tumor growth in vivo: studies with 1400W, a novel inhibitor. Cancer Res. 57: 33003304.
  • Tozer, G. M., Everett, S. A. (1997) Nitric oxide in tumour biology and cancer therapy. Part 1: Physiological aspects. Clin. Oncol. (R Coll Radiol) 9: 282293.
  • Tozer, G. M., Prise, V. E., Chaplin, D. J. (1997) Inhibition of nitric oxide synthase induces a selective reduction in tumor blood flow that is reversible with L-arginine. Cancer Res. 57: 948955.
  • Tozer, G. M., Prise, V. E., Motterlini, R., Poole, B. A., Wilson, J., Chaplin, D. J. (1998) The comparative effects of the NOS inhibitor, Nomega-nitro-L-arginine, and the haemoxygenase inhibitor, zinc protoporphyrin IX, on tumour blood flow. Int. J. Radiat. Oncol. Biol. Phys. 42: 849853.
  • Tschugguel, W., Pustelnik, T., Lass, H., Mildner, M., Weninger, W., Schneeberger, C., Jansen, B., Tschachler, E., Waldhor, T., Huber, J. C., Pehamberger, H. (1999) Inducible nitric oxide synthase (iNOS) expression may predict distant metastasis in human melanoma. Br. J. Cancer 79: 16091612.
  • Tse, G. M., Wong, F. C., Tsang, A. K., Lee, C. S., Lui, P. C., Lo, A. W., Law, B. K., Scolyer, R. A., Karim, R. Z., Putti, T. C. (2005) Stromal nitric oxide synthase (NOS) expression correlates with the grade of mammary phyllodes tumour. J. Clin. Pathol. 58: 600604.
  • Wakabayashi, Y., Shono, T., Hori, S., Matsushima, K., Ono, M., Kuwano, M. (1995) Dual pathways of tubular morphogenesis of vascular endothelial cells by human glioma cells: VEGF/bFGF and IL-8. Jpn. J. Cancer Res. 86: 11891197.
  • Wang, G. Y., Ji, B., Wang, X., Gu, J. H. (2005) Anti-cancer effect of iNOS inhibitor and its correlation with angiogenesis in gastric cancer. World J. Gastroenterol. 11: 38303833.
  • Wang, Z., Cook, T., Alber, S., Liu, K., Kovesdi, I., Watkins, S. K., Vodovotz, Y., Billiar, T. R., Blumberg, D. (2004) Adenoviral gene transfer of the human inducible nitric oxide synthase gene enhances the radiation response of human colorectal cancer associated with alterations in tumor vascularity. Cancer Res. 64: 13861395.
  • Watanabe, K., Hess, A., Michel, O., Yagi, T. (2000) Nitric oxide synthase inhibitor reduces the apoptotic change in the cisplatintreated cochlea of guinea pigs. Anticancer Drugs 11: 731735.
  • Wei, D., Richardson, E. L., Zhu, K., Wang, L., Le, X., He, Y., Huang, S., Xie, K. (2003) Direct demonstration of negative regulation of tumor growth and metastasis by host-inducible nitric oxide synthase. Cancer Res. 63: 38553859.
  • Williams, E. L., Djamgoz, M. B. (2005) Nitric oxide and metastatic cell behaviour. Bioessays 27: 12281238.
  • Wink, D. A., Laval, J. (1994) The Fpg protein, a DNA repair enzyme, is inhibited by the biomediator nitric oxide in vitro and in vivo. Carcinogenesis 15: 21252129.
  • Wink, D. A., Hanbauer, I., Krishna, M. C., DeGraff, W., Gamson, J., Mitchell, J. B. (1993) Nitric oxide protects against cellular damage and cytotoxicity from reactive oxygen species. Proc. Natl. Acad. Sci. USA. 90: 98139817.
  • Wink, D. A., Cook, J. A., Christodoulou, D., Krishna, M. C., Pacelli, R., Kim, S., DeGraff, W., Gamson, J., Vodovotz, Y., Russo, A., Mitchell, J. B. (1997) Nitric oxide and some nitric oxide donor compounds enhance the cytotoxicity of cisplatin. Nitric Oxide 1: 8894.
  • Wink, D. A., Vodovotz, Y., Laval, J., Laval, F., Dewhirst, M. W., Mitchell, J. B. (1998) The multifaceted roles of nitric oxide in cancer. Carcinogenesis 19: 711721.
  • Worthington, J., Robson, T., O'Keeffe, M., Hirst, D. G. (2002) Tumour cell radiosensitization using constitutive (CMV) and radiation inducible (WAF1) promoters to drive the iNOS gene: a novel suicide gene therapy. Gene Ther. 9: 263269.
  • Worthington, J., McCarthy, H. O., Barrett, E., Adams, C., Robson, T., Hirst, D. G. (2004) Use of the radiation-inducible WAF1 promoter to drive iNOS gene therapy as a novel anti-cancer treatment. J. Gene Med. 6: 673680.
  • Worthington, J., Robson, T., Scott, S., Hirst, D. (2005) Evaluation of a synthetic CArG promoter for nitric oxide synthase gene therapy of cancer. Gene Ther. 12: 14171423.
  • Wu, J., Akaike, T., Hayashida, K., Okamoto, T., Okuyama, A., Maeda, H. (2001) Enhanced vascular permeability in solid tumor involving peroxynitrite and matrix metalloproteinases. Jpn. J. Cancer Res. 92: 439451.
  • Xiong, Y., Yuan, L. W., Deng, H. W., Li, Y. J., Chen, B. M. (2001) Elevated serum endogenous inhibitor of nitric oxide synthase and endothelial dysfunction in aged rats. Clin. Exp. Pharmacol. Physiol. 28: 842847.
  • Yamaguchi, K., Saito, H., Oro, S., Tatebe, S., Ikeguchi, M., Tsujitani, S. (2005) Expression of inducible nitric oxide synthase is significantly correlated with expression of vascular endothelial growth factor and dendritic cell infiltration in patients with advanced gastric carcinoma. Oncology 68: 471478.
  • Yang, D. I., Yin, J. H., Ju, T. C., Chen, L. S., Hsu, C. Y. (2004) Nitric oxide and BCNU chemoresistance in C6 glioma cells: role of S-nitrosoglutathione. Free Radic. Biol. Med. 36: 13171328.
  • Yin, J. H., Yang, D. I., Chou, H., Thompson, E. M., Xu, J., Hsu, C. Y. (2001) Inducible nitric oxide synthase neutralizes carbamoylating potential of 1,3-bis(2-chloroethyl)-1-nitrosourea in C6 glioma cells. J. Pharmacol. Exp. Ther. 297: 308315.
  • Zhang, X. M., Xu, Q. (2001) Metastatic melanoma cells escape from immunosurveillance through the novel mechanism of releasing nitric oxide to induce dysfunction of immunocytes. Melanoma Res. 11: 559567.
  • Ziche, M., Morbidelli, L. (2000) Nitric oxide and angiogenesis. J. Neurooncol. 50: 139148.